Associated Papers
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer P et al.
International Journal of Cancer, 2019
30304546 (PubMed )
Supplement: IJC-144-2008-s001.pdf
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
Yu J et al.
Gut, 2015
24951259 (PubMed )
Supplement: gutjnl-2013-306620-s13.pdf
Select a paper to view details